Because caspofungin hasn't been studied as initial therapy, that use isn't recommended. Food and Drug Administration. FDA Approves New Treatment for Invasive Fungal Infection. FDA Talk Paper. Two New Drug Options For Managing Glaucoma Elevated intraocular pressure is both a symptom of glaucoma and a risk factor for its development.
Early management can reduce the patient's risk of optic nerve damage and loss of vision.
Food and Drug Administration. FDA approves two new intraocular pressure lowering drugs for the management of glaucoma. Miconazole nitrate, an antifungal drug sold in such OTC brands as Monistat 3 and Monistat 7, is used to treat vaginal yeast infections. The advisory appeared after the FDA received two reports of abnormal blood clotting tests in women who were using both medications. One woman also developed bruises, bleeding gums, and nosebleed.